66
Participants
Start Date
August 25, 2021
Primary Completion Date
December 21, 2022
Study Completion Date
December 21, 2022
Moderna mRNA-1273 COVID-19 vaccine
100 µg intramuscular injection
Pfizer BNT162b2 COVID-19 vaccine
30 µg intramuscular injection
MRC/UVRI & LSHTM Uganda Research Unit (Site 634-601), Plot 51-59 Nakiwogo Road, P.O. Box 49, Entebbe
St. Francis Hospital, Nsambya (Site 634-607), Nsambya Road Nsambya Hill, P.O. Box 7146, Kampala
University Hospital Zurich (Site 621-201), Raemistrasse 100, Zurich
Washington DC VA Medical Center (Site 009-004), 50 Irving Street, NW., Washington D.C.
Salem VA Medical Center (Site 074-014), 1970 Roanoke Blvd., Salem
Hospital Universitari Arnau de Vilanova (Site 026-035), Institut de Recerca Biomèdica de Lleida, Av. Rovira Roure, 80, Lleida
Wake Forest Baptist Health (Site 210-001), Medical Center Boulevard, Winston-Salem
Duke University Hospital (Site 301-006), 2301 Erwin Road, Durham
Hospital General Universitario Gregorio Marañón (Site 626-001), Servicio de Inmunología Clínica, Departamento de Medicina Interna, Dr. Esquerdo, 46, Madrid
Hillsborough County Health Department, University of South Florida (Site 032-001), 1105 E. Kennedy Blvd., Tampa
Minneapolis VA Medical Center (Site 105-001), 1 Veterans Drive, Minneapolis
UT Southwestern Medical Center (Site 084-001), 1936 Amelia Court, 2nd Floor, Dallas
Parkland Health and Hospital Systems (Site 084-002), James Aston Ambulatory Care Center - Clinical Research Unit, 5303 Harry Hines Blvd., Ste U-9.300, Dallas
CHRISTUS Spohn Shoreline Hospital (Site 080-001), 600 Elizabeth Street, Corpus Christi
Public Health Institute at Denver Health (Site 017-004), 660 Bannock Street, Denver
Cedars-Sinai Medical Center (Site 208-002), 8700 Beverly Blvd, Los Angeles
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (Site 066-002), 1124 W. Carson St., CDCRC, Torrance
San Francisco VAMC (Site 074-002), 4150 Clement Street, San Francisco
Stanford University Hospitals & Clinics (Site 203-003), Stanford University, School of Medicine, 300 Pasteur Dr., Grant Bldg, Room S011, Stanford
Tan Tock Seng Hospital (Site 612-201), National Center for Infectious Diseases (NCID), 11 Jalan Tan Tock Seng, Singapore
Rhode Island Hospital (Site 080-036), 593 Eddy St., Providence
The Miriam Hospital (Site 080-039), 164 Summit Ave., Providence
Institute of Human Virology-Nigeria (Site 612-601), International Research Center of Excellence, Cadastral Zone COO Plot 62, after BAZE University, off CITEC Road, Abuja
Gulu Regional Referral Hospital (Site 634-603), P.O. Box 160, Gulu
Makerere University Lung Institute (634-604), Mulago National Referral Hospital, Kampala
Lira Regional Referral Hospital (Site 634-605), Plot 9/19, 21-41 Ngetta Road Police Road, Lira
Masaka Regional Referral Hospital (Site 634-606), MRC/UVRI and LSHTM Uganda Research Unit, Plot 6 Circle Road, PO Box 556, Masaka
Hospital Universitari Vall d'Hebron (Site 626-033), Passeig Vall Hebron, 119-129, Barcelona
Hospital Clinic de Barcelona (Site 626-004), Carrer de Villaroel 170, Barcelona
Hospital Universitari Germans Trias i Pujol (Site 626-003) Carretera de Canyet, s/n, Barcelona
Collaborators (2)
University of Minnesota
OTHER
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)
NETWORK
University of Copenhagen
OTHER
Kirby Institute
OTHER_GOV
Washington D.C. Veterans Affairs Medical Center
FED
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
NETWORK
National Heart, Lung, and Blood Institute (NHLBI)
NIH
US Department of Veterans Affairs
FED
Prevention and Early Treatment of Acute Lung Injury
OTHER
Cardiothoracic Surgical Trials Network
OTHER
Medical Research Council
OTHER_GOV
National Institute of Allergy and Infectious Diseases (NIAID)
NIH